Treace Medical Concepts
Stock Forecast, Prediction & Price Target
Treace Medical Concepts Financial Estimates
Treace Medical Concepts Revenue Estimates
Treace Medical Concepts EBITDA Estimates
Treace Medical Concepts Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $94.41M N/A | $141.83M 50.22% | $187.11M 31.92% | Avg: $229.80M Low: $221.08M High: $233.88M avg. 22.81% | Avg: $256.21M Low: $250.24M High: $259.78M avg. 11.49% | Avg: $311M Low: $303.75M High: $315.33M avg. 21.38% | Avg: $357.7M Low: $349.36M High: $362.68M avg. 15.01% |
Net Income
% change YoY
| $-24.61M N/A | $-47.29M -92.17% | $-49.52M -4.71% | Avg: $-51.31M Low: $-62.62M High: $-45.03M avg. -3.60% | Avg: $-46.54M Low: $-63.34M High: $-41.98M avg. 9.28% | Avg: $-28.60M Low: $-29.11M High: $-27.73M avg. 38.55% | Avg: $-15.21M Low: $-15.48M High: $-14.75M avg. 46.80% |
EBITDA
% change YoY
| $-15.80M N/A | $-31.80M -101.18% | $-39.00M -22.66% | Avg: $-32.12M Low: $-32.69M High: $-30.90M avg. 17.63% | Avg: $-35.82M Low: $-36.32M High: $-34.98M avg. -11.49% | Avg: $-43.48M Low: $-44.08M High: $-42.46M avg. -21.38% | Avg: $-50.00M Low: $-50.70M High: $-48.84M avg. -15.01% |
EPS
% change YoY
| -$0.45 N/A | -$0.86 -91.11% | -$0.81 5.81% | Avg: -$0.85 Low: -$1.03 High: -$0.74 avg. -4.60% | Avg: -$0.78 Low: -$1.04 High: -$0.69 avg. 8.39% | Avg: -$0.47 Low: -$0.48 High: -$0.46 avg. 39.44% | Avg: -$0.25 Low: -$0.25 High: -$0.24 avg. 46.80% |
Operating Expenses
% change YoY
| $93.10M N/A | $149.15M 60.20% | $203.36M 36.34% | Avg: $196.31M Low: $188.86M High: $199.80M avg. -3.46% | Avg: $218.88M Low: $213.78M High: $221.93M avg. 11.49% | Avg: $265.68M Low: $259.48M High: $269.38M avg. 21.38% | Avg: $305.57M Low: $298.45M High: $309.83M avg. 15.01% |
FAQ
What is Treace Medical Concepts stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.76% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -62.62M, average is -51.31M and high is -45.03M.
What is Treace Medical Concepts stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.67% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $221.08M, average is $229.80M and high is $233.88M.
What is Treace Medical Concepts stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.51% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.03, average is -$0.85 and high is $-0.74.
What is the best performing analyst?
In the last twelve months analysts have been covering Treace Medical Concepts stock. The most successful analyst is Danielle Antalffy.